Explore the full directors' dealings record of PharmaLundensis AB, a publicly traded company based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, PharmaLundensis AB has published 1 public disclosures. Market capitalisation: €4.4m. The latest transaction was disclosed on 24 February 2026 (Purchase). Among the most active insiders: Tord Staffan Håkan Skogvall. All data is openly available.